Low-Field (64 mT) Portable MRI for Rapid Point-of-Care Diagnosis of Dissemination in Space in Patients Presenting with Optic Neuritis

References

1. 1.↵
   1. Giovannoni G,
   2. Butzkueven H,
   3. Dhib-Jalbut S, et al

   . Brain health: time matters in multiple sclerosis. Mult Scler Relat Disord 2016;9(Suppl 1):S5–48 doi:10.1016/j.msard.2016.07.003 pmid:27640924

   CrossRefPubMed
2. 2.↵
   1. Filippi M,
   2. Amato MP,
   3. Centonze D, et al

   . Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion. J Neurol 2022;269:5382–94 doi:10.1007/s00415-022-11193-w pmid:35608658

   CrossRefPubMed
3. 3.↵
   1. Thompson AJ,
   2. Banwell BL,
   3. Barkhof F, et al

   . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17:162–73 doi:10.1016/S1474-4422(17)30470-2 pmid:29275977

   CrossRefPubMed
4. 4.↵
   1. Solomon AJ,
   2. Marrie RA,
   3. Viswanathan S, et al

   . Global barriers to the diagnosis of multiple sclerosis: data from the Multiple Sclerosis International Federation Atlas of MS, Third Edition. Neurology 2023;101:e624–35 doi:10.1212/WNL.0000000000207481 pmid:37321866

   Abstract/FREE Full Text
5. 5.↵
   1. Sheth KN,
   2. Mazurek MH,
   3. Yuen MM, et al

   . Assessment of brain injury using portable, low-field magnetic resonance imaging at the bedside of critically ill patients. JAMA Neurol 2021;78:41–47 doi:10.1001/jamaneurol.2020.3263 pmid:32897296

   CrossRefPubMed
6. 6.↵
   1. Kuoy E,
   2. Glavis-Bloom J,
   3. Hovis G, et al

   . Point-of-care brain MRI: preliminary results from a single-center retrospective study. Radiology 2022;305:666–71 doi:10.1148/radiol.211721 pmid:35916678

   CrossRefPubMed
7. 7.↵
   1. Chetcuti K,
   2. Chilingulo C,
   3. Goyal MS, et al

   . Implementation of a low-field portable MRI scanner in a resource-constrained environment: our experience in Malawi. AJNR Am J Neuroradiol 2022;43:670–74 doi:10.3174/ajnr.A7494 pmid:35450856

   Abstract/FREE Full Text
8. 8.↵
   1. DesRoche CN,
   2. Johnson AP,
   3. Hore EB, et al

   . Feasibility and cost analysis of portable MRI implementation in a remote setting in Canada. Can J Neurol Sci 2023;1–10 doi:10.1017/cjn.2023.250 pmid:37434471

   CrossRefPubMed
9. 9.↵
   1. Islam O,
   2. Lin AW,
   3. Bharatha A

   . Potential application of ultra-low field portable MRI in the ICU to improve CT and MRI access in Canadian hospitals: a multi-center retrospective analysis. Front Neurol 2023;14:1220091 doi:10.3389/fneur.2023.1220091 pmid:37808492

   CrossRefPubMed
10. 10.↵
    1. Mazurek MH,
    2. Cahn BA,
    3. Yuen MM, et al

    . Portable, bedside, low-field magnetic resonance imaging for evaluation of intracerebral hemorrhage. Nat Commun 2021;12:5119 doi:10.1038/s41467-021-25441-6 pmid:34433813

    CrossRefPubMed
11. 11.↵
    1. Mazurek MH,
    2. Parasuram NR,
    3. Peng TJ, et al

    . Detection of intracerebral hemorrhage using low-field, portable magnetic resonance imaging in patients with stroke. Stroke 2023;54:2832–41 doi:10.1161/STROKEAHA.123.043146 pmid:37795593

    CrossRefPubMed
12. 12.↵
    1. Yuen MM,
    2. Prabhat AM,
    3. Mazurek MH, et al

    . Portable, low-field magnetic resonance imaging enables highly accessible and dynamic bedside evaluation of ischemic stroke. Sci Adv 2022;8:eabm3952 doi:10.1126/sciadv.abm3952 pmid:35442729

    CrossRefPubMed
13. 13.↵
    1. Sujijantarat N,
    2. Koo AB,
    3. Jambor I, et al

    . Low‐field portable magnetic resonance imaging for post‐thrombectomy assessment of ongoing brain injury. SVIN 2023;3:e000921 doi:10.1161/SVIN.123.000921

    CrossRef
14. 14.↵
    1. Sheth KN,
    2. Yuen MM,
    3. Mazurek MH, et al

    . Bedside detection of intracranial midline shift using portable magnetic resonance imaging. Sci Rep 2022;12:67 doi:10.1038/s41598-021-03892-7 pmid:34996970

    CrossRefPubMed
15. 15.↵
    1. Beekman R,
    2. Crawford A,
    3. Mazurek MH, et al

    . Bedside monitoring of hypoxic ischemic brain injury using low-field, portable brain magnetic resonance imaging after cardiac arrest. Resuscitation 2022;176:150–58 doi:10.1016/j.resuscitation.2022.05.002 pmid:35562094

    CrossRefPubMed
16. 16.↵
    1. Hong CS,
    2. Lamsam LA,
    3. Yadlapalli V, et al

    . Portable MRI to assess optic chiasm decompression after endoscopic endonasal resection of sellar and suprasellar lesions. J Neurosurg 2023;139:1664–70 doi:10.3171/2023.5.JNS23174 pmid:37347618

    CrossRefPubMed
17. 17.↵
    1. Mateen FJ,
    2. Cooley CZ,
    3. Stockmann JP, et al

    . Low-field portable brain MRI in CNS demyelinating disease. Mult Scler Relat Disord 2021;51:102903 doi:10.1016/j.msard.2021.102903 pmid:33780808

    CrossRefPubMed
18. 18.↵
    1. Arnold TC,
    2. Tu D,
    3. Okar SV, et al

    . Sensitivity of portable low-field magnetic resonance imaging for multiple sclerosis lesions. Neuroimage Clin 2022;35:103101 doi:10.1016/j.nicl.2022.103101 pmid:35792417

    CrossRefPubMed
19. 19.↵
    1. De Havenon A,
    2. Parasuram NR,
    3. Crawford AL, et al

    . Identification of white matter hyperintensities in routine emergency department visits using portable bedside magnetic resonance imaging. J Am Heart Assoc 2023;12:e029242 doi:10.1161/JAHA.122.029242 pmid:37218590

    CrossRefPubMed
20. 20.↵
    1. Toosy AT,
    2. Mason DF,
    3. Miller DH

    . Optic neuritis. Lancet Neurol 2014;13:83–99 doi:10.1016/S1474-4422(13)70259-X pmid:24331795

    CrossRefPubMedWeb of Science
21. 21.↵
    The clinical profile of optic neuritis: experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 1991;109:1673–78 doi:10.1001/archopht.1991.01080120057025 pmid:1841573

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Jalloul M,
    2. Miranda‐Schaeubinger M,
    3. Noor AM, et al

    . MRI scarcity in low‐ and middle‐income countries. NMR Biomed 2023;36:e5022 doi:10.1002/nbm.5022 pmid:37574441

    CrossRefPubMed
23. 23.↵
    1. Geethanath S,
    2. Vaughan JT

    . Accessible magnetic resonance imaging: a review. Magn Reson Imaging 2019;49 doi:10.1002/jmri.26638

    CrossRefPubMed
24. 24.↵
    1. Moir M,
    2. Barua B,
    3. Wannamaker H

    . Waiting Your Turn: Wait Times for Health Care in Canada, 2023 Report. 2023 Fraser Institute. Published July 2023. https://www.fraserinstitute.org/sites/default/files/waiting-your-turn-2023.pdf. Accessed February 5, 2024
25. 25.↵
    1. Arnold TC,
    2. Freeman CW,
    3. Litt B, et al

    . Low‐field MRI: clinical promise and challenges. J Magn Reson Imaging 2023;57:25–44 doi:10.1002/jmri.28408 pmid:36120962

    CrossRefPubMed
26. 26.↵
    1. Murali S,
    2. Ding H,
    3. Adedeji F, et al

    . Bringing MRI to low‐ and middle‐income countries: directions, challenges and potential solutions. NMR Biomed 2024;37:e4992 doi:10.1002/nbm.4992 pmid:37401341

    CrossRefPubMed
27. 27.↵
    1. Lecler A,
    2. El Sanharawi I,
    3. El Methni J, et al

    . Improving detection of multiple sclerosis lesions in the posterior fossa using an optimized 3D-FLAIR sequence at 3T. AJNR Am J Neuroradiol 2019;40:1170–76 doi:10.3174/ajnr.A6107 pmid:31248862

    Abstract/FREE Full Text
28. 28.↵
    1. Brownlee WJ,
    2. Miszkiel KA,
    3. Tur C, et al

    . Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis. Neurology 2018;91:e1130–34 doi:10.1212/WNL.0000000000006207 pmid:30120132

    Abstract/FREE Full Text
29. 29.↵
    1. Vidal-Jordana A,
    2. Rovira A,
    3. Calderon W, et al

    . Adding the optic nerve in multiple sclerosis diagnostic criteria: a longitudinal, prospective, multicenter study. Neurology 2024;102:e200805 doi:10.1212/WNL.0000000000207805 pmid:38165378

    CrossRefPubMed
30. 30.↵
    1. Bsteh G,
    2. Hegen H,
    3. Altmann P, et al

    ; for VMSD (Vienna Multiple Sclerosis Database) Group. Diagnostic performance of adding the optic nerve region assessed by optical coherence tomography to the diagnostic criteria for multiple sclerosis. Neurology 2023;101:e784–93 doi:10.1212/WNL.0000000000207507 pmid:37400245

    Abstract/FREE Full Text
31. 31.↵
    1. Iglesias JE,
    2. Schleicher R,
    3. Laguna S, et al

    . Quantitative brain morphometry of portable low-field-strength MRI using super-resolution machine learning. Radiology 2023;306:e220522 doi:10.1148/radiol.220522 pmid:36346311

    CrossRefPubMed
32. 32.↵
    1. Lau V,
    2. Xiao L,
    3. Zhao Y, et al

    . Pushing the limits of low‐cost ultra‐low‐field MRI by dual‐acquisition deep learning 3D superresolution. Magn Reson Med 2023;90:400–16 doi:10.1002/mrm.29642 pmid:37010491

    CrossRefPubMed
33. 33.↵
    1. Islam KT,
    2. Zhong S,
    3. Zakavi P, et al

    . Improving portable low-field MRI image quality through image-to-image translation using paired low- and high-field images. Sci Rep 2023;13:21183 doi:10.1038/s41598-023-48438-1 pmid:38040835

    CrossRefPubMed
34. 34.↵
    1. Waddington DEJ,
    2. Boele T,
    3. Maschmeyer R, et al

    . High-sensitivity in vivo contrast for ultra-low field magnetic resonance imaging using superparamagnetic iron oxide nanoparticles. Sci Adv 2020;6:eabb0998 doi:10.1126/sciadv.abb0998 pmid:32733998

    FREE Full Text
35. 35.↵
    1. Van Zandwijk JK,
    2. Simonis FFJ,
    3. Heslinga FG, et al

    . Comparing the signal enhancement of a gadolinium based and an iron-oxide based contrast agent in low-field MRI. PLoS One 2021;16:e0256252 doi:10.1371/journal.pone.0256252 pmid:34403442

    CrossRefPubMed